Dr. Michal Obrzut, MD

Dr. Obrzut practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Obrzut's NPI, 1992983944, was assigned on February 1, 2008. Dr. Obrzut graduated from Perelman School of Medicine - Philadelphia in 2002. Dr. Obrzut's Connecticut license number on file is 045924.

Dr. Obrzut's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Obrzut's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Obrzut is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Obrzut to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Obrzut practices, 2 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Obrzut's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Obrzut is board certified in diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Obrzut's licenses on file in 13 states: Connecticut, California, Florida, Michigan, Ohio, Virginia, Illinois, Tennessee, Indiana, Maryland, New Mexico, Wisconsin and New York.

CMS data shows 177 Medicare services from Dr. Obrzut across 5 procedure codes in 2024, for 138 Medicare patients. Medicare paid $19,050 for them.

CMS counts 138 Medicare patients who saw Dr. Obrzut in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Obrzut's median patient age at 66, with 62% women.

In 2024, Dr. Obrzut wrote 74 Medicare Part D claims for 39 patients. 82% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $87 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Obrzut for performance year 2024, reported through an alternative payment model (APM). Dr. Obrzut accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Obrzut as offering telehealth.

Dmand AI links 19 papers to Dr. Obrzut, published from 2008 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Vertebral Artery, Brain and Brain Neoplasms. Dr. Obrzut has published most often in World Neurosurg. Dr. Obrzut's most frequent co-authors are Badih A. Adada, MD, Baha'Eddin Ahmad Ibrahim Muhsen and Rocco M. Dabecco, DO.

CMS Open Payments shows 21 general payments to Dr. Obrzut from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. DePuy Synthes Sales Inc. paid the most, $397.

Dr. Obrzut graduated from Perelman School of Medicine - Philadelphia in 2002.

Dr. Obrzut is in network with 6 carriers, including Cigna, United Healthcare and Health Alliance Plan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.